Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine

Alberto Grandi(Toscana Life Sciences)
bioRxiv (Cold Spring Harbor Laboratory)
July 13, 2021
Cited by 3


Related Papers